Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness

Cholangiocarcinoma (CCA) is the second most common primary liver malignancy with extremely poor therapeutic outcome due to high drug resistance, widespread metastasis and lack of effective treatment options. CCA progression and metastasis are regulated by multiple biological factors including multip...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Xie, Ying, Wang, Yazhe, Li, Jing, Hang, Yu, Jaramillo, Lee, Wehrkamp, Cody J., Phillippi, Mary Anne, Mohr, Ashley M., Chen, Yi, Talmon, Geoffrey A., Mott, Justin L., Oupický, David
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134930/
https://ncbi.nlm.nih.gov/pubmed/30214622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.26506
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados